Search research articles
Contact Us
Filters
Showing results (731-740 of 755) with videos related to
Page
of 76
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
The Journal of Rheumatology
|
February 15, 2007
Outcome measurements in scleroderma: results from a delphi exercise
Hashim Gazi, Janet E Pope, Philip Clements, et al.
Arthritis Care & Research
|
October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna, John D Fitzgerald, Puja P Khanna, et al.
Arthritis Care & Research
|
October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna, Puja P Khanna, John D Fitzgerald, et al.
Plos One
|
January 3, 2018
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
Olga Y Gorlova, Yafang Li, Ivan Gorlov, et al.
Seminars in Arthritis and Rheumatism
|
January 13, 2015
Antinuclear antibody-negative systemic sclerosis
Gloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Arthritis Care & Research
|
April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Lancet. Rheumatology
|
December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung, Cathie Spino, Richard McLain, et al.
The Journal of Rheumatology
|
October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definition
George A Wells, Maarten Boers, Beverley Shea, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
Cosimo Bruni, Maya H Buch, Daniel E Furst, et al.
Page
of 76
Search research articles
Search
Showing results (731-740 of 755) with videos related to
Sort By:
Page
of 76
American Journal of Respiratory and Critical Care Medicine
|
August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
The Journal of Rheumatology
|
February 15, 2007
Outcome measurements in scleroderma: results from a delphi exercise
Hashim Gazi, Janet E Pope, Philip Clements, et al.
Arthritis Care & Research
|
October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna, John D Fitzgerald, Puja P Khanna, et al.
Arthritis Care & Research
|
October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna, Puja P Khanna, John D Fitzgerald, et al.
Plos One
|
January 3, 2018
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
Olga Y Gorlova, Yafang Li, Ivan Gorlov, et al.
Seminars in Arthritis and Rheumatism
|
January 13, 2015
Antinuclear antibody-negative systemic sclerosis
Gloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Arthritis Care & Research
|
April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Lancet. Rheumatology
|
December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung, Cathie Spino, Richard McLain, et al.
The Journal of Rheumatology
|
October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definition
George A Wells, Maarten Boers, Beverley Shea, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
Cosimo Bruni, Maya H Buch, Daniel E Furst, et al.
Page
of 76